JILLIAN VAN ESSENDELFT: Open Payments
NPI 1083209217 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 20 payments from 14 companies in 2025. Trend: 2023 $94 · 2024 $236 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Organon LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| Grifols USA, LLC | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| CooperSurgical, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| LSI SOLUTIONS INC | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $22 |
Products named: MYFEMBREE, GEMTESA, NEXPLANON, Wegovy, Prolastin-C Liquid, Veozah, Paragard T 380A, BOTOX.
Industry payments across NC — which companies pay providers there.
